GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectis SA (NAS:CLLS) » Definitions » Float Percentage Of Total Shares Outstanding

CLLS (Cellectis) Float Percentage Of Total Shares Outstanding : 80.40% (As of May. 05, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Cellectis Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cellectis's float shares is 80.63 Mil. Cellectis's total shares outstanding is 100.29 Mil. Cellectis's float percentage of total shares outstanding is 80.40%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cellectis's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cellectis's Institutional Ownership is 12.75%.

Cellectis Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Cellectis's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=80.63/100.29
=80.40%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellectis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectis SA (NAS:CLLS) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XPAR:GNFT XPAR:IPH XPAR:DBV XPAR:NANO XPAR:OSE XPAR:MAAT XPAR:TNG XPAR:ADOC XPAR:ALSEN XPAR:IVA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
0WA2:UK ALCLS:France ZVAA:Germany ZVA:Germany ZVAA:Germany
Address
8, rue de la Croix Jarry, Paris, FRA, 75013
Website
https://www.cellectis.com
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.